Target Name: INSYN2A
NCBI ID: G642938
Other Name(s): InSyn2 | INSYN2 | INSY2_HUMAN | protein FAM196A | Inhibitory synaptic factor 2A | family with sequence similarity 196 member A | inhibitory synaptic protein 2 | C10orf141 | FAM196A | inhibitory synaptic factor 2A

Insyn2A: A Potential Drug Target and Biomarker

INSYN2A is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the Insulin-like growth factor (IGF) family, which includes proteins that are involved in cell growth and survival. While INSYN2A is not well-studied, research has identified several potential functions for this protein. This article will explore the potential implications of INSYN2A as a drug target or biomarker.

Potential Functions as a Drug Target

INSYN2A has been shown to play a role in several cellular processes that are important for brain development and function. One of the most promising functions of INSYN2A is its role in the development and maintenance of neuronal stem cells. These stem cells are responsible for the formation and maintenance of the nervous system, and they are critical for the development of new neurons and the repair of damaged tissue.

INSYN2A has been shown to promote the self-renewal and survival of neuronal stem cells. This is important because these stem cells are often used to treat various neurological disorders, such as cancer, neurodegenerative diseases, and developmental disorders. By promoting the survival and self-renewal of neuronal stem cells, INSYN2A may have implications for the treatment of these disorders.

Another potential function of INSYN2A is its role in the regulation of cell death.INSYN2A has been shown to play a role in the production of programmed cell death (apoptosis), which is a natural process that helps remove damaged or dysfunctional cells from the body. This is important because cells that are no longer needed or are damaged can contribute to the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Potential Use as a Biomarker

INSYN2A may also be used as a biomarker for certain diseases. As discussed above, INSYN2A is expressed in a variety of tissues and has been shown to play a role in the development and maintenance of neuronal stem cells. This suggests that it may be a useful biomarker for the treatment of conditions that affect these stem cells, such as cancer, neurodegenerative diseases, and developmental disorders.

In addition to its potential as a drug target, INSYN2A may also be used as a biomarker for certain diseases. For example, INSYN2A has been shown to be expressed in the brains of individuals with Alzheimer's disease, which is a neurodegenerative disorder that is characterized by the progressive loss of brain cells. This suggests that INSYN2A may be a useful biomarker for the diagnosis and treatment of Alzheimer's disease.

Conclusion

INSYN2A is a protein that has been shown to play a role in several cellular processes that are important for brain development and function. While more research is needed, the potential implications of INSYN2A as a drug target or biomarker are significant. As discussed above, INSYN2A has been shown to promote the self-renewal and survival of neuronal stem cells and to play a role in the regulation of cell death. Additionally, INSYN2A has been shown to be expressed in the brains of individuals with Alzheimer's disease, which suggests that it may be a useful biomarker for this disease.

Overall, while more research is needed, the potential implications of INSYN2A as a drug target or biomarker are promising. Further studies are needed to fully understand the functions of this protein and its potential as a therapeutic agent.

Protein Name: Inhibitory Synaptic Factor 2A

Functions: Component of the protein machinery at the inhibitory synapses, probably acting as a scaffold. Inhibitory synapses dampen neuronal activity through postsynaptic hyperpolarization. This synaptic inhibition is fundamental for the functioning of the central nervous system, shaping and orchestrating the flow of information through neuronal networks to generate a precise neural code

More Common Targets

INSYN2B | Integrator complex | Integrin alpha1beta1 (VLA-1) receptor | Integrin alpha2beta1 (VLA-2) receptor | Integrin alpha2beta3 Receptor | Integrin alpha3beta1 receptor | Integrin alpha4beta1 (VLA-4) receptor | Integrin alpha4beta7 (LPAM-1) receptor | Integrin alpha5beta1 (VLA-5) receptor | Integrin alpha5beta3 receptor | Integrin alpha6beta1 Receptor | Integrin alpha6beta4 receptor | Integrin alpha7beta1 Receptor | Integrin alpha9beta1 receptor | Integrin alphaEbeta7 receptor | Integrin alphaLbeta2 (LFA-1) receptor | Integrin alphaMbeta2 (MAC-1) Receptor | Integrin alphavbeta1 | Integrin alphavbeta3 (vitronectin) receptor | Integrin alphavbeta5 receptor | Integrin alphavbeta6 receptor | Integrin alphavbeta8 Receptor | Integrin Receptor | Integrin-linked kinase | Interferon | Interferon-alpha (IFN-alpha) | Interferon-gamma Receptor | Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex | Interleukin-27 (IL-27) Complex | Interleukin-39 (IL-39) | Interleukin-7 receptor | Intraflagellar transport complex | Intraflagellar transport complex A | Intraflagellar transport complex B | Intrinsic Tenase Complex | INTS1 | INTS10 | INTS11 | INTS12 | INTS13 | INTS14 | INTS15 | INTS2 | INTS3 | INTS4 | INTS4P1 | INTS4P2 | INTS5 | INTS6 | INTS6L | INTS6L-AS1 | INTS6P1 | INTS7 | INTS8 | INTS9 | INTU | Invariant T Cell Receptor | INVS | Inward Rectifier Potassium Channel | IP6K1 | IP6K2 | IP6K3 | IPCEF1 | IPMK | IPO11 | IPO11-LRRC70 | IPO13 | IPO4 | IPO5 | IPO7 | IPO8 | IPO9 | IPO9-AS1 | IPP | IPPK | IPW | IQCA1 | IQCA1L | IQCB1 | IQCC | IQCD | IQCE | IQCF1 | IQCF2 | IQCF3 | IQCF5-AS1 | IQCF6 | IQCG | IQCH | IQCH-AS1 | IQCJ | IQCJ-SCHIP1 | IQCK